Detected ·
Maculaser Ltd
€4.4M—
Maculaser Ltd has successfully closed a EUR 4.4 million funding round, co-led by ZEISS Ventures and M2Care, with participation from Innovestor, Metsola Ventures, existing shareholders, and support from Business Finland. The company is developing temperature-controlled retinal laser therapy for early, non-damaging intervention to preserve vision before irreversible retinal damage occurs.
- Website
- —
- linkedin.com/company/maculaser
- Amount
- €4 400 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-10 20:02:42 UTC
- Signal ID
- 7015b813-8448-465f-ac51-abda84f9071b
As the API returns it
{
"id": "7015b813-8448-465f-ac51-abda84f9071b",
"created_at": "2026-08-10T20:02:42.040255Z",
"company_name": "Maculaser Ltd",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/maculaser",
"event_type": "funding",
"funding_amount": 4400000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*Maculaser Ltd has successfully closed a EUR 4.4 million funding round, co-led by ZEISS Ventures and M2Care, with participation from Innovestor, Metsola Ventures, existing shareholders, and support from Business Finland. The company is developing temperature-controlled retinal laser therapy for early, non-damaging intervention to preserve vision before irreversible retinal damage occurs.*"
}